HDHD5 promotes triple-negative breast cancer growth and drives EMT-associated phenotypes via regulating S100A4
{{output}}
Purpose: Triple-negative breast cancer (TNBC) displays an aggressive clinicopathological profile. Despite cytotoxic chemotherapy being the primary systemic therapy, complete responses are achieved in fewer than 30% of patients, h... ...
